NBIX insider plans sale of 36,400 shares stock

A holder of NBIX common stock has filed a notice of proposed sale under Rule 144, covering 36,400 common shares with an aggregate market value of $4,853,940.

Rhea-AI Filing Summary

A holder of NBIX common stock has filed a notice of proposed sale under Rule 144, covering 36,400 common shares with an aggregate market value of $4,853,940. The shares are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of 01/16/2026. Common shares outstanding were 99,705,698 as of this notice.

The 36,400 shares were acquired on 01/16/2026 by exercising stock options granted by the issuer and paid for in cash. In the past three months, the seller listed as Kyle Gano previously sold 300 common shares on 11/04/2025 for gross proceeds of $42,591. By signing the notice, the seller represents that they do not know of any undisclosed material adverse information about the issuer’s operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the NBIX Form 144 filing disclose?

The filing discloses a planned Rule 144 sale of 36,400 NBIX common shares with an aggregate market value of $4,853,940, to be sold on NASDAQ through Morgan Stanley Smith Barney LLC around 01/16/2026.

How were the 36,400 NBIX shares being sold under Rule 144 acquired?

The 36,400 common shares were acquired on 01/16/2026 through an exercise of stock options from the issuer, with the exercise price paid in cash on the same date.

How many NBIX shares are outstanding in this Form 144 notice?

The notice states that the number of NBIX common shares outstanding is 99,705,698 at the time of the filing, providing context for the size of the planned sale.

What recent NBIX stock sales by the same seller are disclosed?

The filing lists that Kyle Gano sold 300 common shares on 11/04/2025 for $42,591 in gross proceeds during the past three months.

Which broker is handling the planned NBIX share sale?

The planned sale of NBIX common stock will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

What representation does the NBIX seller make in this Rule 144 notice?

By signing, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, as required under the Rule 144 notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/16/2026 - 04:21 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001567160
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NEUROCRINE BIOSCIENCES INC
SEC File Number	000-22705
Address of Issuer	6027 Edgewood Bend Court San Diego CALIFORNIA 92130
Phone	8586177600
Name of Person for Whose Account the Securities are To Be Sold	KYLE GANO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	36400	4853940.00	99705698	01/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/16/2026	Exercise of Stock Options	Issuer			36400	01/16/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KYLE GANO 6027 Edgewood Bend Court San Diego CA 92130	Common	11/04/2025	300	42591.00

144: Remarks and Signature

Remarks
Date of Notice	01/16/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kyle Gano
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)